Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_assertion type Assertion NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_head.
- NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_assertion description "[The low mutational frequency in our study discounts sequence variations in DAL-1/4.1B as the main mechanism underlying participation of this gene in the neoplastic transformation of meningiomas, and suggests that other inactivating mechanisms, such as epigenetic changes, may participate in DAL1/4.1B silencing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_provenance.
- NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_assertion evidence source_evidence_literature NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_provenance.
- NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_assertion SIO_000772 16142420 NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_provenance.
- NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_assertion wasDerivedFrom befree-2016 NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_provenance.
- NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_assertion wasGeneratedBy ECO_0000203 NP512116.RAB53ANXg-4apNTFerEQa07foVTq7gJgHfUoMtTWllMZ8130_provenance.